DnB Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.4M Sell
441,574
-33,954
-7% -$3.65M 0.2% 82
2025
Q1
$48M Buy
475,528
+15,256
+3% +$1.54M 0.22% 80
2024
Q4
$41.1M Buy
460,272
+198,985
+76% +$17.8M 0.18% 93
2024
Q3
$21.9M Buy
261,287
+11,434
+5% +$958K 0.1% 158
2024
Q2
$19.2M Buy
249,853
+16,007
+7% +$1.23M 0.09% 160
2024
Q1
$16M Sell
233,846
-274,746
-54% -$18.8M 0.08% 174
2023
Q4
$29.4M Sell
508,592
-5,264
-1% -$304K 0.15% 117
2023
Q3
$27.1M Buy
513,856
+13,500
+3% +$713K 0.16% 111
2023
Q2
$27.1M Sell
500,356
-822
-0.2% -$44.5K 0.16% 116
2023
Q1
$25.1M Sell
501,178
-167,114
-25% -$8.36M 0.16% 119
2022
Q4
$30.9M Sell
668,292
-22,816
-3% -$1.06M 0.22% 103
2022
Q3
$26.8M Sell
691,108
-2,769
-0.4% -$107K 0.21% 107
2022
Q2
$25.9M Sell
693,877
-10,073
-1% -$375K 0.18% 113
2022
Q1
$31.2M Sell
703,950
-70,268
-9% -$3.11M 0.19% 114
2021
Q4
$32.9M Buy
774,218
+14,345
+2% +$609K 0.19% 107
2021
Q3
$33M Buy
759,873
+3,437
+0.5% +$149K 0.21% 94
2021
Q2
$32.3M Sell
756,436
-94,530
-11% -$4.04M 0.21% 94
2021
Q1
$32.9M Sell
850,966
-97,592
-10% -$3.77M 0.24% 82
2020
Q4
$34.1M Buy
948,558
+561,274
+145% +$20.2M 0.3% 67
2020
Q3
$14.8M Buy
387,284
+32,885
+9% +$1.26M 0.16% 106
2020
Q2
$12.4M Buy
354,399
+12,018
+4% +$422K 0.15% 119
2020
Q1
$11.2M Sell
342,381
-26,015
-7% -$849K 0.16% 113
2019
Q4
$16.7M Buy
368,396
+17,281
+5% +$781K 0.16% 114
2019
Q3
$14.3M Buy
351,115
+11,915
+4% +$485K 0.16% 110
2019
Q2
$14.6M Sell
339,200
-11,550
-3% -$496K 0.17% 104
2019
Q1
$13.5M Sell
350,750
-13,532
-4% -$519K 0.15% 112
2018
Q4
$12.9M Buy
364,282
+192,752
+112% +$6.81M 0.17% 111
2018
Q3
$6.6M Buy
171,530
+780
+0.5% +$30K 0.07% 186
2018
Q2
$5.58M Buy
170,750
+8,300
+5% +$271K 0.07% 200
2018
Q1
$4.44M Buy
162,450
+11,300
+7% +$309K 0.05% 229
2017
Q4
$3.75M Buy
151,150
+17,500
+13% +$434K 0.05% 252
2017
Q3
$3.9M Sell
133,650
-1,600
-1% -$46.7K 0.05% 227
2017
Q2
$3.75M Sell
135,250
-2,500
-2% -$69.3K 0.05% 226
2017
Q1
$3.43M Buy
137,750
+15,100
+12% +$376K 0.05% 234
2016
Q4
$2.65M Buy
122,650
+5,200
+4% +$112K 0.05% 242
2016
Q3
$2.8M Buy
117,450
+8,100
+7% +$193K 0.06% 228
2016
Q2
$2.56M Buy
109,350
+3,900
+4% +$91.1K 0.05% 230
2016
Q1
$1.98M Buy
105,450
+29,000
+38% +$545K 0.04% 254
2015
Q4
$1.41M Buy
76,450
+9,900
+15% +$183K 0.03% 270
2015
Q3
$1.09M Hold
66,550
0.03% 302
2015
Q2
$1.18M Hold
66,550
0.03% 298
2015
Q1
$1.18M Sell
66,550
-44,000
-40% -$781K 0.03% 319
2014
Q4
$1.46M Buy
110,550
+16,600
+18% +$220K 0.03% 284
2014
Q3
$1.11M Buy
93,950
+18,500
+25% +$218K 0.02% 302
2014
Q2
$963K Buy
+75,450
New +$963K 0.02% 330
2013
Q4
$560K Sell
46,550
-2,100
-4% -$25.2K 0.01% 332
2013
Q3
$571K Buy
48,650
+24,800
+104% +$291K 0.02% 334
2013
Q2
$221K Buy
+23,850
New +$221K 0.01% 375